Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 188

1.

Recipient leukocyte infusion enhances the local and systemic graft-versus-neuroblastoma effect of allogeneic bone marrow transplantation in mice.

Willems L, Fevery S, Sprangers B, Rutgeerts O, Lenaerts C, Ibrahimi A, Gijsbers R, Van Gool S, Waer M, Billiau AD.

Cancer Immunol Immunother. 2013 Nov;62(11):1733-44. doi: 10.1007/s00262-013-1479-6. Epub 2013 Oct 1.

PMID:
24081484
2.

Reduction of myeloid-derived suppressor cells reinforces the anti-solid tumor effect of recipient leukocyte infusion in murine neuroblastoma-bearing allogeneic bone marrow chimeras.

Dierckx de Casterlé I, Fevery S, Rutgeerts O, Poosti F, Struyf S, Lenaerts C, Waer M, Billiau AD, Sprangers B.

Cancer Immunol Immunother. 2018 Apr;67(4):589-603. doi: 10.1007/s00262-017-2114-8. Epub 2018 Jan 3.

PMID:
29299660
4.

Recipient lymphocyte infusion in MHC-matched bone marrow chimeras induces a limited lymphohematopoietic host-versus-graft reactivity but a significant antileukemic effect mediated by CD8+ T cells and natural killer cells.

De Somer L, Sprangers B, Fevery S, Rutgeerts O, Lenaerts C, Boon L, Waer M, Billiau AD.

Haematologica. 2011 Mar;96(3):424-31. doi: 10.3324/haematol.2010.035329. Epub 2010 Nov 25.

5.

Invariant NKT cells are required for antitumor responses induced by host-versus-graft responses.

Saito TI, Li HW, Sykes M.

J Immunol. 2010 Aug 15;185(4):2099-105. doi: 10.4049/jimmunol.0901985. Epub 2010 Jul 14.

8.
9.
11.

Immunomodulation with dendritic cells and donor lymphocyte infusion converge to induce graft vs neuroblastoma reactions without GVHD after allogeneic bone marrow transplantation.

Ash S, Stein J, Askenasy N, Yaniv I.

Br J Cancer. 2010 Nov 9;103(10):1597-605. doi: 10.1038/sj.bjc.6605924. Epub 2010 Oct 26.

12.

Graft-vs.-host and graft-vs.-leukemia reactions after delayed infusions of donor T-subsets.

Johnson BD, Becker EE, Truitt RL.

Biol Blood Marrow Transplant. 1999;5(3):123-32.

13.
16.
17.

Graft-versus-host-reactive donor CD4 cells can induce T cell-mediated rejection of the donor marrow in mixed allogeneic chimeras prepared with nonmyeloablative conditioning.

Kim YM, Mapara MY, Down JD, Johnson KW, Boisgerault F, Akiyama Y, Benichou G, Pelot M, Zhao G, Sykes M.

Blood. 2004 Jan 15;103(2):732-9. Epub 2003 Sep 25.

PMID:
14512313
18.

Paradoxical effects of IFN-gamma in graft-versus-host disease reflect promotion of lymphohematopoietic graft-versus-host reactions and inhibition of epithelial tissue injury.

Wang H, Asavaroengchai W, Yeap BY, Wang MG, Wang S, Sykes M, Yang YG.

Blood. 2009 Apr 9;113(15):3612-9. doi: 10.1182/blood-2008-07-168419. Epub 2009 Feb 10.

19.

Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.

Li JM, Gorechlad J, Larsen CP, Waller EK.

Biol Blood Marrow Transplant. 2006 Dec;12(12):1239-49.

20.

A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.

Nestvold JM, Omdal BK, Dai KZ, Martens A, Benestad HB, Vaage JT, Rolstad B.

Transplantation. 2008 Jan 15;85(1):102-11. doi: 10.1097/01.tp.0000296856.53493.1f.

PMID:
18192919

Supplemental Content

Support Center